Dymon Asia Capital (Singapore)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.94M Buy
63,130
+38,130
+153% +$3.08M 0.21% 69
2026
Q1
$2.17M Buy
+25,000
New +$2.39M 0.22% 120
2025
Q2
Sell
-8,000
Closed -$719K 193
2025
Q1
$719K Buy
+8,000
New +$716K 0.16% 94

Other funds holding MDT

Dymon Asia Capital (Singapore)'s MDT Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) increased its Medtronic (MDT) stake by 153% in Q2 2026, buying an estimated $3.08M and bringing the position to 63,130 shares worth $4.94M. The position accounts for 0.21% of the portfolio, ranked #69.

Dymon Asia Capital (Singapore) first reported a position in MDT in Q1 2025 and has held it in 3 quarters since. 959 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Dymon Asia Capital (Singapore) held 63,130 shares of Medtronic worth $4.94M as of Q2 2026.
  • Dymon Asia Capital (Singapore) bought 38,130 Medtronic shares in Q2 2026, an estimated $3.08M.
  • Medtronic made up 0.21% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #69 holding.
  • Dymon Asia Capital (Singapore) first reported a position in Medtronic in Q1 2025 and has held it in 3 quarters since.
  • 959 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.